Immunovant
IMVT
$29.39
Share price
-1.04%
Change (1 day)
60.78%
Change (1 year)
Categories
Immunovant (IMVT) - Net assets
Net assets on the balance sheet as of December 2023 : $0.67 B
According to Immunovant's latest financial reports the company has $0.67 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Immunovant - Net assets on balance sheet (from 2019 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-03-31 | $0.36 B | -22.84% |
| 2022-03-31 | $0.46 B | 20.01% |
| 2021-03-31 | $0.39 B | 316.16% |
| 2020-03-31 | $94.06 M | |
| 2018-12-31 | $0.02 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.22 B | -67.01% | 🇺🇸 USA |